UCB Financial Statements From 2010 to 2024
| UCB Stock | EUR 180.00 5.85 3.36% |
Check UCB SA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among UCB SA's main balance sheet or income statement drivers, such as , as well as many indicators such as . UCB financial statements analysis is a perfect complement when working with UCB SA Valuation or Volatility modules.
UCB |
UCB SA Company Return On Equity Analysis
UCB SA's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current UCB SA Return On Equity | 0.11 |
Most of UCB SA's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, UCB SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, UCB SA has a Return On Equity of 0.1069. This is 100.45% lower than that of the Pharmaceuticals sector and 100.29% lower than that of the Health Care industry. The return on equity for all Belgium stocks is 134.48% lower than that of the firm.
UCB SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining UCB SA's current stock value. Our valuation model uses many indicators to compare UCB SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across UCB SA competition to find correlations between indicators driving UCB SA's intrinsic value. More Info.UCB SA is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers reporting about 0.44 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for UCB SA is roughly 2.28 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the UCB SA's earnings, one of the primary drivers of an investment's value.About UCB SA Financial Statements
UCB SA shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although UCB SA investors may analyze each financial statement separately, they are all interrelated. The changes in UCB SA's assets and liabilities, for example, are also reflected in the revenues and expenses on on UCB SA's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
UCB SA, a biopharmaceutical company, researches, develops, manufactures, sells, and distributes biopharmaceutical solutions for people living with neurology and immunology conditions. The company was founded in 1928 and is headquartered in Brussels, Belgium. UCB SA operates under Biotechnology classification in Belgium and is traded on Brussels Stock Exchange. It employs 6828 people.
Pair Trading with UCB SA
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if UCB SA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in UCB SA will appreciate offsetting losses from the drop in the long position's value.Moving against UCB Stock
| 0.67 | CFEB | Compagnie d Entreprises | PairCorr |
| 0.63 | BEKB | NV Bekaert SA | PairCorr |
| 0.62 | BNB | Banque nationale | PairCorr |
The ability to find closely correlated positions to UCB SA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace UCB SA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back UCB SA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling UCB SA to buy it.
The correlation of UCB SA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as UCB SA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if UCB SA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for UCB SA can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for UCB Stock Analysis
When running UCB SA's price analysis, check to measure UCB SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UCB SA is operating at the current time. Most of UCB SA's value examination focuses on studying past and present price action to predict the probability of UCB SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UCB SA's price. Additionally, you may evaluate how the addition of UCB SA to your portfolios can decrease your overall portfolio volatility.